David E. Parkin

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Alan N. Gordon, John Fleagle, David Guthrie et al. · Journal of Clinical Oncology · 2001 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

P. Vasey, Gordon C. Jayson, Amanda Gordon et al. · JNCI Journal of the National Cancer Institute · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +16

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding

S. B. Pinion, David E. Parkin, D. R. Abramovich et al. · BMJ · 1994 · 280 citations

Medicine, Gynecology, Surgery +11

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer

Vanessa N. Harry, Scott I. Semple, Fiona J. Gilbert et al. · Gynecologic Oncology · 2008 · 224 citations

Medicine, Oncology, Radiology +16